FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stimulator, Electrical, Implanted, For Parkinsonian Tremor

PMA: P960009 · Supplement: S318 · Decision Oct 12, 2018
Classifications
1
FEI Numbers
30
Registration Numbers
30

Basic Information

Device Name
Stimulator, Electrical, Implanted, For Parkinsonian Tremor
Trade Name
Medtronic DBS Therapy for Epilepsy
PMA Number
P960009
Supplement Number
S318
Device Class
FDA Class 3
Product Code
MHY
Generic Name
Stimulator, electrical, implanted, for parkinsonian tremor
Medical Specialty
Unknown
Advisory Committee
Neurology
Decision
Approved
Decision Code
APPR
Decision Date
October 12, 2018
Date Received
May 24, 2018
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Postapproval Study Protocol
Expedited Review
N

Advisory Committee Statement

Approval for the Medtronic DBS Therapy for expanding the indications to include Epilepsy. Bilateral stimulation of the anterior nucleus of the thalamus (ANT) using the Medtronic DBS System for epilepsy is indicated as an adjunctive therapy for reducing the frequency of seizures in individuals 18 years of age or older diagnosed with epilepsy characterized by partial - onset seizures, with or without secondary generalization, that are refractory to three or more antiepileptic medications. The Medtronic DBS System for Epilepsy has demonstrated safety and effectiveness in patients who averaged six or more seizures per month over the three most recent months prior to implant of the DBS system (with no more than 30 days between seizures). The Medtronic DBS System for Epilepsy has not been evaluated in patients with less frequent seizures.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MHY Stimulator, Electrical, Implanted, For Parkinsonian Tremor